For: | Hollis M, Nair K, Vyas A, Chaturvedi LS, Gambhir S, Vyas D. MicroRNAs potential utility in colon cancer: Early detection, prognosis, and chemosensitivity. World J Gastroenterol 2015; 21(27): 8284-8292 [PMID: 26217080 DOI: 10.3748/wjg.v21.i27.8284] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v21/i27/8284.htm |
Number | Citing Articles |
1 |
Taiki Sato, Aya Shiba‐Ishii, Yunjung Kim, Tomoko Dai, Ryan Edbert Husni, JeongMin Hong, Junko Kano, Shingo Sakashita, Tatsuo Iijima, Masayuki Noguchi. miR‐3941: A novel microRNA that controls IGBP1 expression and is associated with malignant progression of lung adenocarcinoma. Cancer Science 2017; 108(3): 536 doi: 10.1111/cas.13148
|
2 |
Clemens Franz, Laila Jötten, Michael Wührl, Sibylle Hartmann, Fee Klupp, Thomas Schmidt, Martin Schneider. Protective effect of miR‐18a in resected liver metastases of colorectal cancer and FOLFOX treatment. Cancer Reports 2023; 6(12) doi: 10.1002/cnr2.1899
|
3 |
Feridun Akkafa, İsmail Koyuncu, Ebru Temiz, Hasan Dagli, Fuat Dïlmec, Halit Akbas. miRNA-mediated apoptosis activation through TMEM 48 inhibition in A549 cell line. Biochemical and Biophysical Research Communications 2018; 503(1): 323 doi: 10.1016/j.bbrc.2018.06.023
|
4 |
Christian T Wohnhaas, Ramona Schmid, Marcel Rolser, Eric Kaaru, Dominik Langgartner, Kathrin Rieber, Benjamin Strobel, Claudia Eisele, Franziska Wiech, Ines Jakob, Florian Gantner, Ivona Herichova, Richard Vinisko, Wulf O Böcher, Sudha Visvanathan, Fei Shen, Mark Panzenbeck, Ernest Raymond, Stefan O Reber, Denis Delić, Patrick Baum. Fecal MicroRNAs Show Promise as Noninvasive Crohn’s Disease Biomarkers. Crohn's & Colitis 360 2020; 2(1) doi: 10.1093/crocol/otaa003
|
5 |
Ruirui Cheng, Chunya Lu, Guojun Zhang, Guowei Zhang, Guoqiang Zhao. Overexpression of miR-203 increases the sensitivity of NSCLC A549/H460 cell lines to cisplatin by targeting Dickkopf-1. Oncology Reports 2017; 37(4): 2129 doi: 10.3892/or.2017.5505
|
6 |
Jonas Dohmen, Alexander Semaan, Makbule Kobilay, Martin Zaleski, Vittorio Branchi, Anja Schlierf, Karina Hettwer, Steffen Uhlig, Gunther Hartmann, Jörg C. Kalff, Hanno Matthaei, Philipp Lingohr, Stefan Holdenrieder. Diagnostic Potential of Exosomal microRNAs in Colorectal Cancer. Diagnostics 2022; 12(6): 1413 doi: 10.3390/diagnostics12061413
|
7 |
Zhenfei Wang, Hao Yang, Daguang Ma, Yongping Mu, Xiaohui Tan, Qin Hao, Li Feng, Junqing Liang, Wen Xin, Yongxia Chen, Yingcai Wu, Yongfeng Jia, Haiping Zhao. Serum PIWI-Interacting RNAs piR-020619 and piR-020450 Are Promising Novel Biomarkers for Early Detection of Colorectal Cancer. Cancer Epidemiology, Biomarkers & Prevention 2020; 29(5): 990 doi: 10.1158/1055-9965.EPI-19-1148
|
8 |
Hui Zhang, Zhuo Wang, Rong Ma, Jianzhong Wu, Jifeng Feng. MicroRNAs as biomarkers for the progression and prognosis of colon carcinoma. International Journal of Molecular Medicine 2018; doi: 10.3892/ijmm.2018.3792
|
9 |
James Church. Molecular genetics of colorectal cancer. Seminars in Colon and Rectal Surgery 2016; 27(4): 172 doi: 10.1053/j.scrs.2016.04.013
|
10 |
Ehsan Gharib, Ehsan Nazemalhosseini‐Mojarad, Kaveh Baghdar, Zahra Nayeri, Hossein Sadeghi, Sama Rezasoltani, Arezo Jamshidi‐Fard, Pegah Larki, Amir Sadeghi, Mehrdad Hashemi, Hamid Asadzadeh Aghdaei. Identification of a stool long non‐coding RNAs panel as a potential biomarker for early detection of colorectal cancer. Journal of Clinical Laboratory Analysis 2021; 35(2) doi: 10.1002/jcla.23601
|
11 |
Shuqiao Hu, Jiehuan Lin, Canxing Wu, Jun Ma, Shanshan Chen, Funan Chen. Evaluation of Circulating Tumor Cells-DNA Methylated Separation Nano-Polylactic-co-Glycolic Acid Magnetic Beads with Epithelial Cell Adhesion Molecul/Epidermal Growth Factor Receptor Double Antibody Modification and Its Application in Lung Cancer Diagnosis. Science of Advanced Materials 2021; 13(12): 2302 doi: 10.1166/sam.2021.4161
|
12 |
Youjun Mao, Yuqing Jia, Huijun Zhu, Wei Wang, Qin Jin, Fang Huang, Shu Zhang, Xiaoqiang Li. High expression of PFTK1 in cancer cells predicts poor prognosis in colorectal cancer. Molecular Medicine Reports 2017; 16(1): 224 doi: 10.3892/mmr.2017.6560
|
13 |
Mamie Gao, Allen Zhong, Neil Patel, Chiraag Alur, Dinesh Vyas. High throughput RNA sequencing utility for diagnosis and prognosis in colon diseases. World Journal of Gastroenterology 2017; 23(16): 2819-2825 doi: 10.3748/wjg.v23.i16.2819
|
14 |
Kenneth KW To, Christy WS Tong, Mingxia Wu, William CS Cho. MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside. World Journal of Gastroenterology 2018; 24(27): 2949-2973 doi: 10.3748/wjg.v24.i27.2949
|
15 |
Yanfeng L�, Bingbing Han, Hualong Yu, Zhenghua Cui, Zhiwen Li, Jianxin Wang. Berberine regulates the microRNA‑21‑ITGΒ4‑PDCD4 axis and inhibits colon cancer viability. Oncology Letters 2018; doi: 10.3892/ol.2018.7997
|
16 |
Naghmeh Shirafkan, Behzad Mansoori, Ali Mohammadi, Navid Shomali, Mehri Ghasbi, Behzad Baradaran. MicroRNAs as novel biomarkers for colorectal cancer: New outlooks. Biomedicine & Pharmacotherapy 2018; 97: 1319 doi: 10.1016/j.biopha.2017.11.046
|
17 |
Ming Jiang, Li-Yang Zhou, Nan Xu, Qing An. Down-regulation of miR-500 and miR-628 suppress non-small cell lung cancer proliferation, migration and invasion by targeting ING1. Biomedicine & Pharmacotherapy 2018; 108: 1628 doi: 10.1016/j.biopha.2018.09.145
|
18 |
Xin Lin, Lu Han, Chuncai Gu, Yihong Lai, Qiuhua Lai, Qingyuan Li, Chengcheng He, Yan Meng, Lei Pan, Side Liu, Aimin Li. MiR-452-5p promotes colorectal cancer progression by regulating an ERK/MAPK positive feedback loop. Aging 2021; 13(5): 7608 doi: 10.18632/aging.202657
|
19 |
Jun Wang, Yong-Xi Song, Bin Ma, Jia-Jun Wang, Jing-Xu Sun, Xiao-Wan Chen, Jun-Hua Zhao, Yu-Chong Yang, Zhen-Ning Wang. Regulatory Roles of Non-Coding RNAs in Colorectal Cancer. International Journal of Molecular Sciences 2015; 16(8): 19886 doi: 10.3390/ijms160819886
|
20 |
Eline H. Schreuders, Esmée J. Grobbee, Manon C. W. Spaander, Ernst J. Kuipers. Advances in Fecal Tests for Colorectal Cancer Screening. Current Treatment Options in Gastroenterology 2016; 14(1): 152 doi: 10.1007/s11938-016-0076-0
|
21 |
Nahal Eshghifar, Elham Badrlou, Farkhondeh Pouresmaeili. The roles of miRNAs’ clinical efficiencies in the colorectal cancer pathobiology: A review article. Human Antibodies 2020; 28(4): 273 doi: 10.3233/HAB-200417
|
22 |
Jun Shibamoto, Tomohiro Arita, Hirotaka Konishi, Satoshi Kataoka, Hirotaka Furuke, Wataru Takaki, Jun Kiuchi, Hiroki Shimizu, Yusuke Yamamoto, Shuhei Komatsu, Atsushi Shiozaki, Yoshiaki Kuriu, Eigo Otsuji. Roles of miR-4442 in Colorectal Cancer: Predicting Early Recurrence and Regulating Epithelial-Mesenchymal Transition. Genes 2023; 14(7): 1414 doi: 10.3390/genes14071414
|
23 |
Yinbo Liu, Xiaodi Yan, Jun Li, Xinxin Ren, Qi Wu, Gang-Ao Wang, Yuqing Chen, Xiaolei Zhu. miRNA-Disease Association Prediction based on Heterogeneous Graph Transformer with Multi-view similarity and Random Auto-encoder. 2023 IEEE International Conference on Bioinformatics and Biomedicine (BIBM) 2023; : 885 doi: 10.1109/BIBM58861.2023.10385493
|
24 |
Kengo Kuroda, Tomokazu Fukuda, Marija Krstic-Demonacos, Constantinos Demonacos, Kazuhiko Okumura, Hiroshi Isogai, Miwa Hayashi, Kazuki Saito, Emiko Isogai. miR-663a regulates growth of colon cancer cells, after administration of antimicrobial peptides, by targeting CXCR4-p21 pathway. BMC Cancer 2017; 17(1) doi: 10.1186/s12885-016-3003-9
|
25 |
Youyong Tang, Zhijun Zhang, Xingguo Song, Miao Yu, Limin Niu, Yajing Zhao, Li Wang, Xianrang Song, Li Xie, Nicola Silvestris. Tumor-Derived Exosomal miR-620 as a Diagnostic Biomarker in Non-Small-Cell Lung Cancer. Journal of Oncology 2020; 2020: 1 doi: 10.1155/2020/6691211
|
26 |
Yongchen Guo, Yonghua Bao, Wancai Yang. Regulatory miRNAs in Colorectal Carcinogenesis and Metastasis. International Journal of Molecular Sciences 2017; 18(4): 890 doi: 10.3390/ijms18040890
|
27 |
Salman Guraya. Prognostic significance of circulating microRNA-21 expression in esophageal, pancreatic and colorectal cancers; a systematic review and meta-analysis. International Journal of Surgery 2018; 60: 41 doi: 10.1016/j.ijsu.2018.10.030
|
28 |
Andrea Angius, Paolo Uva, Giovanna Pira, Maria Rosaria Muroni, Giovanni Sotgiu, Laura Saderi, Elena Uleri, Maurizio Caocci, Gabriele Ibba, Maria Rosaria Cesaraccio, Caterina Serra, Ciriaco Carru, Alessandra Manca, Francesca Sanges, Alberto Porcu, Antonia Dolei, Antonio Mario Scanu, Paolo Cossu Rocca, Maria Rosaria De Miglio. Integrated Analysis of miRNA and mRNA Endorses a Twenty miRNAs Signature for Colorectal Carcinoma. International Journal of Molecular Sciences 2019; 20(16): 4067 doi: 10.3390/ijms20164067
|
29 |
Tao Fan, Wei Wang, Boyou Zhang, Yao Xu, Lei Chen, Shize Pan, Hao Hu, Qing Geng. Regulatory mechanisms of microRNAs in lung cancer stem cells. SpringerPlus 2016; 5(1) doi: 10.1186/s40064-016-3425-5
|
30 |
Li Wang, Cheng Zhong, Stefano Pascarella. Prediction of miRNA-Disease Association Using Deep Collaborative Filtering. BioMed Research International 2021; 2021: 1 doi: 10.1155/2021/6652948
|
31 |
Amin Saberinia, Amin Alinezhad, Fatemeh Jafari, Setareh Soltany, Reza Akhavan Sigari. Oncogenic miRNAs and target therapies in colorectal cancer. Clinica Chimica Acta 2020; 508: 77 doi: 10.1016/j.cca.2020.05.012
|
32 |
Timur R. Samatov, Vladimir V. Galatenko, Nadezhda V. Senyavina, Alexey V. Galatenko, Maxim Yu Shkurnikov, Svetlana A. Tonevitskaya, Dmitry A. Sakharov, Uwe Marx, Hermann Ehrlich, Udo Schumacher, Alexander G. Tonevitsky. miRNA-mediated expression switch of cell adhesion genes driven by microcirculation in chip. BioChip Journal 2017; 11(4): 262 doi: 10.1007/s13206-017-1305-x
|
33 |
Jing Qiu, Yongzhi Zhang, Hu Chen, Zhi Guo. MicroRNA-488 inhibits proliferation, invasion and EMT in osteosarcoma cell lines by targeting aquaporin 3. International Journal of Oncology 2018; doi: 10.3892/ijo.2018.4483
|
34 |
Giuseppe Sammarco, Gaetano Gallo, Giuseppina Vescio, Arcangelo Picciariello, Gilda De Paola, Mario Trompetto, Giuseppe Currò, Michele Ammendola. Mast Cells, microRNAs and Others: The Role of Translational Research on Colorectal Cancer in the Forthcoming Era of Precision Medicine. Journal of Clinical Medicine 2020; 9(9): 2852 doi: 10.3390/jcm9092852
|
35 |
Viktor Limanskiy, Arpita Vyas, Lakshmi Shankar Chaturvedi, Dinesh Vyas. Harnessing the potential of gene editing technology using CRISPR in inflammatory bowel disease. World Journal of Gastroenterology 2019; 25(18): 2177-2187 doi: 10.3748/wjg.v25.i18.2177
|
36 |
Li X, Han Y, Zhang A, Miao J, Sun H, Yan G, Wu F, Wang X. Mechanistic and Therapeutic Advances in Colon Cancer: A Systematic Review. Open Journal of Proteomics and Genomics 2019; : 001 doi: 10.17352/ojpg.000008
|
37 |
Madhav Madurantakam Royam, Chellan Kumarasamy, Siddhartha Baxi, Ajay Gupta, Nachimuthu Ramesh, Gothandam Kodiveri Muthukaliannan, Rama Jayaraj. Current Evidence on miRNAs as Potential Theranostic Markers for Detecting Chemoresistance in Colorectal Cancer: A Systematic Review and Meta-Analysis of Preclinical and Clinical Studies. Molecular Diagnosis & Therapy 2019; 23(1): 65 doi: 10.1007/s40291-019-00381-6
|
38 |
Jian Li, Yuxiang Chen, Xiong Guo, Ling Zhou, Zeming Jia, Yaping Tang, Ling Lin, Weidong Liu, Caiping Ren. Inhibition of miR-15b decreases cell migration and metastasis in colorectal cancer. Tumor Biology 2016; 37(7): 8765 doi: 10.1007/s13277-015-4396-9
|
39 |
Vermont P. Dia, Hari B. Krishnan. BG-4, a novel anticancer peptide from bitter gourd (Momordica charantia), promotes apoptosis in human colon cancer cells. Scientific Reports 2016; 6(1) doi: 10.1038/srep33532
|
40 |
Early detection of lung cancer biomarkers through biosensor technology: A review. Journal of Pharmaceutical and Biomedical Analysis 2019; 164: 93 doi: 10.1016/j.jpba.2018.10.017
|
41 |
Shanthi Sabarimurugan, Madurantakam Royam Madhav, Chellan Kumarasamy, Ajay Gupta, Siddharta Baxi, Sunil Krishnan, Rama Jayaraj. Prognostic Value of MicroRNAs in Stage II Colorectal Cancer Patients: A Systematic Review and Meta-Analysis. Molecular Diagnosis & Therapy 2020; 24(1): 15 doi: 10.1007/s40291-019-00440-y
|
42 |
GUANQUN GE, WEI ZHANG, LIGANG NIU, YU YAN, YU REN, YULIANG ZOU. miR-215 functions as a tumor suppressor in epithelial ovarian cancer through regulation of the X-chromosome-linked inhibitor of apoptosis. Oncology Reports 2016; 35(3): 1816 doi: 10.3892/or.2015.4482
|
43 |
Relationship between BRAF V600E and KRAS mutations in stool for identifying colorectal cancer: A cross-sectional study. Annals of Medicine and Surgery 2020; 60: 121 doi: 10.1016/j.amsu.2020.10.027
|
44 |
Surachai Maijaroen, Nisachon Jangpromma, Jureerut Daduang, Sompong Klaynongsruang. KT2 and RT2 modified antimicrobial peptides derived from Crocodylus siamensis Leucrocin I show activity against human colon cancer HCT-116 cells. Environmental Toxicology and Pharmacology 2018; 62: 164 doi: 10.1016/j.etap.2018.07.007
|
45 |
Ga‐Bin Park, Jee‐Yeong Jeong, Daejin Kim. Modified TLR‐mediated downregulation of miR‐125b‐5p enhances CD248 (endosialin)‐induced metastasis and drug resistance in colorectal cancer cells. Molecular Carcinogenesis 2020; 59(2): 154 doi: 10.1002/mc.23137
|
46 |
Hui Zhang, Yuanyuan Du, Zhuo Wang, Rui Lou, Jianzhong Wu, Jifeng Feng. Integrated Analysis of Oncogenic Networks in Colorectal Cancer Identifies GUCA2A as a Molecular Marker. Biochemistry Research International 2019; 2019: 1 doi: 10.1155/2019/6469420
|
47 |
Petra Vychytilova-Faltejskova, Jana Merhautova, Tana Machackova, Irene Gutierrez-Garcia, José Garcia-Solano, Lenka Radova, Dominika Brchnelova, Katerina Slaba, Marek Svoboda, Jana Halamkova, Regina Demlova, Igor Kiss, Rostislav Vyzula, Pablo Conesa-Zamora, Ondrej Slaby. MiR-215-5p is a tumor suppressor in colorectal cancer targeting EGFR ligand epiregulin and its transcriptional inducer HOXB9. Oncogenesis 2017; 6(11) doi: 10.1038/s41389-017-0006-6
|
48 |
Ying Yang, Wen-Jian Meng, Zi-Qiang Wang. MicroRNAs in Colon and Rectal Cancer - Novel Biomarkers from Diagnosis to Therapy. Endocrine, Metabolic & Immune Disorders - Drug Targets 2020; 20(8): 1211 doi: 10.2174/1871530320666200506075219
|
49 |
Andrea Lampis, Michele Ghidini, Margherita Ratti, Milko B. Mirchev, Ali Fuat Okuducu, Nicola Valeri, Jens Claus Hahne. Circulating Tumour DNAs and Non-Coding RNAs as Liquid Biopsies for the Management of Colorectal Cancer Patients. Gastrointestinal Disorders 2020; 2(3): 212 doi: 10.3390/gidisord2030022
|
50 |
Chandra Kishore, Devarajan Karunagaran. Non-coding RNAs as emerging regulators and biomarkers in colorectal cancer. Molecular and Cellular Biochemistry 2022; 477(6): 1817 doi: 10.1007/s11010-022-04412-5
|
51 |
Shengli Yuan, Fengying Tao, Xinglin Zhang, Yan Zhang, Xingxing Sun, Dapeng Wu. Role of Wnt/β-Catenin Signaling in the Chemoresistance Modulation of Colorectal Cancer. BioMed Research International 2020; 2020: 1 doi: 10.1155/2020/9390878
|
52 |
Surasak Wanram, Namphon Klaewkla, Parichart Pinyosri. Downregulation of Serum miR-133b and miR-206 Associate with Clinical
Outcomes of Progression as Monitoring Biomarkers for Metastasis
Colorectal Cancer Patients. MicroRNA 2024; 13(1): 56 doi: 10.2174/0122115366266024240101075745
|
53 |
Jun Zhao, Jingjie Cao, Lurong Zhou, Yunyi Du, Xiaoling Zhang, Bo Yang, Yangjun Gao, Yu Wang, Ning Ma, Wei Yang. MiR‑1260b inhibitor enhances the chemosensitivity of colorectal cancer cells to fluorouracil by targeting PDCD4/IGF1. Oncology Letters 2018; doi: 10.3892/ol.2018.9307
|
54 |
Yaqin Tang, Xiao He, Zhenxia Zhou, Jiakun Tang, Rong Guo, Xuli Feng. Highly sensitive and selective miRNA detection based on a closed ring probe and multiple signal amplification. Chemical Communications 2016; 52(96): 13905 doi: 10.1039/C6CC07719F
|
55 |
Likun Hou, Jian Chen, Yuhui Zheng, Chunyan Wu. Critical role of miR-155/FoxO1/ROS axis in the regulation of non-small cell lung carcinomas. Tumor Biology 2016; 37(4): 5185 doi: 10.1007/s13277-015-4335-9
|
56 |
Baofei Sun, Junchao Xue, Jun Li, Fei Luo, Xiong Chen, Yonglian Liu, Qingling Wang, Caihua Qi, Zhonglan Zou, Aihua Zhang, Qizhan Liu. Circulating miRNAs and their target genes associated with arsenism caused by coal-burning. Toxicology Research 2017; 6(2): 162 doi: 10.1039/C6TX00428H
|
57 |
S. Kumar, M. Vijayan, J.S. Bhatti, P.H. Reddy. Molecular Biology of Aging. Progress in Molecular Biology and Translational Science 2017; 146: 47 doi: 10.1016/bs.pmbts.2016.12.013
|
58 |
Yaqun Ye, Binbin Gu, Yi Wang, Sudan Shen, Wei Huang. E2F1‐mediated MNX1‐AS1‐miR‐218‐5p‐SEC61A1 feedback loop contributes to the progression of colon adenocarcinoma. Journal of Cellular Biochemistry 2019; 120(4): 6145 doi: 10.1002/jcb.27902
|
59 |
Marcela González-Montoya, Blanca Hernández-Ledesma, Jose Manuel Silván, Rosalva Mora-Escobedo, Cristina Martínez-Villaluenga. Peptides derived from in vitro gastrointestinal digestion of germinated soybean proteins inhibit human colon cancer cells proliferation and inflammation. Food Chemistry 2018; 242: 75 doi: 10.1016/j.foodchem.2017.09.035
|
60 |
Reza Ghanbari, Neda Mosakhani, Virinder K. Sarhadi, Gemma Armengol, Nazila Nouraee, Ashraf Mohammadkhani, Samaneh Khorrami, Ehsan Arefian, Mahdi Paryan, Reza Malekzadeh, Sakari Knuutila. Simultaneous Underexpression of let-7a-5p and let-7f-5p microRNAs in Plasma and Stool Samples from Early Stage Colorectal Carcinoma. Biomarkers in Cancer 2015; : BIC.S25252 doi: 10.4137/BIC.S25252
|
61 |
E. Danese, A. M Minicozzi, M. Benati, E. Paviati, G. Lima-Oliveira, M. Gusella, F. Pasini, G. L Salvagno, M. Montagnana, G. Lippi. Reference miRNAs for colorectal cancer: analysis and verification of current data. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-08784-3
|
62 |
Changxuan You, Liming Jin, Qi Xu, Bo Shen, Xuelong Jiao, Xuewu Huang. Expression of miR‑21 and miR‑138 in colon cancer and its effect on cell proliferation and prognosis. Oncology Letters 2018; doi: 10.3892/ol.2018.9864
|
63 |
Yu-Shen Wu, Huapeng Lin, Duke Chen, Ziying Yi, Beilei Zeng, Yicheng Jiang, Guosheng Ren. A four-miRNA signature as a novel biomarker for predicting survival in endometrial cancer. Gene 2019; 697: 86 doi: 10.1016/j.gene.2019.01.046
|
64 |
Weiwen Yan, Qiuyun Wu, Wenxi Yao, Yan Li, Yi Liu, Jiali Yuan, Ruhui Han, Jingjin Yang, Xiaoming Ji, Chunhui Ni. MiR-503 modulates epithelial-mesenchymal transition in silica-induced pulmonary fibrosis by targeting PI3K p85 and is sponged by lncRNA MALAT1. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-11904-8
|
65 |
Saray Duran-Sanchon, Elena Vila-Navarro, Maria Marcuello, Juan José Lozano, Jenifer Muñoz, Joaquín Cubiella, Maria Soledad Diez, Luis Bujanda, Angel Lanas, Rodrigo Jover, Vicent Hernández, Enrique Quintero, Marta Herreros-Villanueva, Ana Carmen Martín, Rosa Pérez-Palacios, Rocio Arroyo, Antoni Castells, Meritxell Gironella. Validation of miR-1228-3p as Housekeeping for MicroRNA Analysis in Liquid Biopsies from Colorectal Cancer Patients. Biomolecules 2019; 10(1): 16 doi: 10.3390/biom10010016
|
66 |
Qingguo Li, Xin Liang, Yuwei Wang, Xianke Meng, Ye Xu, Sanjun Cai, Zhimin Wang, Jianwen Liu, Guoxiang Cai. miR-139-5p Inhibits the Epithelial-Mesenchymal Transition and Enhances the Chemotherapeutic Sensitivity of Colorectal Cancer Cells by Downregulating BCL2. Scientific Reports 2016; 6(1) doi: 10.1038/srep27157
|
67 |
Yili Tao, Shoubin Zhan, Yanbo Wang, Geyu Zhou, Hongwei Liang, Xi Chen, Hong Shen. Baicalin, the major component of traditional Chinese medicine Scutellaria baicalensis induces colon cancer cell apoptosis through inhibition of oncomiRNAs. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-32734-2
|
68 |
Yuqin Pan, Jian Qin, Huiling Sun, Tao Xu, Shukui Wang, Bangshun He. Mir-485-5P As A Potential Biomarker and Tumor Suppressor in Human Colorectal Cancer. Biomarkers in Medicine 2020; 14(3): 239 doi: 10.2217/bmm-2019-0534
|
69 |
R. Susanti, Muchamad Dafip, Dewi Mustikaningtyas, Agung Putra. Predictive action of oncomiR in suppressing TP53 signaling pathway in hypoxia‐conditioned colon cancer cell line HCT‐116. Cell Biology International 2024; 48(12): 1891 doi: 10.1002/cbin.12243
|
70 |
Qiang Fu, Jindai Zhang, Gaofeng Huang, Yonglei Zhang, Minghai Zhao, Yongchao Zhang, Jianguo Xie. Retracted: microRNA‐29b inhibits cell growth and promotes sensitivity to oxaliplatin in colon cancer by targeting FOLR1. BioFactors 2020; 46(1): 136 doi: 10.1002/biof.1579
|
71 |
Yin Lam Chu, Harriet Li, Pik Lan Amanda Ng, Siu Ting Kong, Hao Zhang, Yusheng Lin, William Chi Shing Tai, Allen Chi Shing Yu, Aldrin Kay Yuen Yim, Hin Fung Tsang, William Chi Shing Cho, Sze Chuen Cesar Wong. The potential of circulating exosomal RNA biomarkers in cancer. Expert Review of Molecular Diagnostics 2020; 20(7): 665 doi: 10.1080/14737159.2020.1745064
|
72 |
Viviana Costa, Alessia Lo Dico, Aroldo Rizzo, Francesca Rajata, Marco Tripodi, Riccardo Alessandro, Alice Conigliaro. MiR-675-5p supports hypoxia induced epithelial to mesenchymal transition in colon cancer cells. Oncotarget 2017; 8(15): 24292 doi: 10.18632/oncotarget.14464
|
73 |
Caterina Vicentini, Federica Calore, Giovanni Nigita, Paolo Fadda, Michele Simbolo, Nicola Sperandio, Claudio Luchini, Rita T. Lawlor, Carlo Maria Croce, Vincenzo Corbo, Matteo Fassan, Aldo Scarpa. Exosomal miRNA signatures of pancreatic lesions. BMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01287-y
|
74 |
Xiao Yuan, Hao Wang, Aman Xu, Xingyang Zhu, Yanqing Zhan, Wenbin Wang. Ubiquitin‑specific peptidase 22 promotes proliferation and metastasis in human colon cancer. Oncology Letters 2019; doi: 10.3892/ol.2019.10872
|
75 |
Chunya Lu, Huaqi Wang, Shanshan Chen, Rui Yang, Hui Li, Guojun Zhang. Baicalein inhibits cell growth and increases cisplatin sensitivity of A549 and H460 cells via miR‐424‐3p and targeting PTEN/PI3K/Akt pathway. Journal of Cellular and Molecular Medicine 2018; 22(4): 2478 doi: 10.1111/jcmm.13556
|
76 |
Fateme Karimi Dermani, Ishwaree Datta, Saeideh Gholamzadeh Khoei. MicroRNA-452: a double-edged sword in multiple human cancers. Clinical and Translational Oncology 2023; 25(5): 1189 doi: 10.1007/s12094-022-03041-0
|
77 |
Ming-Chao Wei, Yu-Min Wang, Da-Wei Wang. miR-130a-Mediated KLF3 Can Inhibit the Growth of Lung Cancer Cells. Cancer Management and Research 2021; : 2995 doi: 10.2147/CMAR.S281203
|
78 |
Jaber Alfaifi, Adeline Germain, Anne-Charlotte Heba, Djésia Arnone, Laura Gailly, Ndeye Coumba Ndiaye, Emilie Viennois, Bénédicte Caron, Laurent Peyrin-Biroulet, Natacha Dreumont. Deep Dive Into MicroRNAs in Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2023; 29(6): 986 doi: 10.1093/ibd/izac250
|
79 |
Ebtehal Abduh Ahmed, Ramesa Shafi Bhat, Jilani P. Shaik, Mohammad Alanazi, Abdullah Al Amri, Abeer Aldbass, Sooad Al Daihan. MicroRNA Gene Expression Profile of Colorectal Cancer in Saudi Population. International Journal of Pharmacology 2024; 20(2): 149 doi: 10.3923/ijp.2024.149.157
|
80 |
Weiwei Zhang, Yuequan Zhu, Yuan Zhou, Junjie Wang, Ping Jiang, Lixiang Xue. miRNA‐31 increases radiosensitivity through targeting STK40 in colorectal cancer cells. Asia-Pacific Journal of Clinical Oncology 2022; 18(3): 267 doi: 10.1111/ajco.13602
|
81 |
Laura Agulló, Ana Segura, Samanta Ortuño-Miquel, Ana Teresa Brinca, Rosa Micol-Ponce, Vicente Arrarte, María Rosa Ponce, Pau Miró-Martínez, Thomas Zandonai, Ana M. Peiró. Circulating miRNA-21 is an innovative biomarker for cardiovascular events in erectile dysfunction patients. Frontiers in Cardiovascular Medicine 2024; 11 doi: 10.3389/fcvm.2024.1301925
|
82 |
Haochen Zhao, Linai Kuang, Xiang Feng, Quan Zou, Lei Wang. A Novel Approach Based on a Weighted Interactive Network to Predict Associations of MiRNAs and Diseases. International Journal of Molecular Sciences 2018; 20(1): 110 doi: 10.3390/ijms20010110
|
83 |
Luyao Zhang, Bo Li, Beilin Zhang, Hua Zhang, Jian Suo. miR‑361 enhances sensitivity to 5‑fluorouracil by targeting the FOXM1‑ABCC5/10 signaling pathway in colorectal cancer . Oncology Letters 2019; doi: 10.3892/ol.2019.10741
|
84 |
Xin Zhou, Zipeng Lu, Tongshan Wang, Zebo Huang, Wei Zhu, Yi Miao. Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis. Gene 2018; 673: 181 doi: 10.1016/j.gene.2018.06.037
|
85 |
Uyen-Thao Le, Peter Bronsert, Francesco Picardo, Sabine Riethdorf, Benedikt Haager, Bartosz Rylski, Martin Czerny, Friedhelm Beyersdorf, Sebastian Wiesemann, Klaus Pantel, Bernward Passlick, Jussuf Thomas Kaifi, Severin Schmid. Intraoperative detection of circulating tumor cells in pulmonary venous blood during metastasectomy for colorectal lung metastases. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-26410-8
|
86 |
Zhiyang Jiang, Guoqing Tao, Yanfei Zhu. The Expression and Clinical Significance of miRNA-135a and Bach1 in Colorectal Cancer. International Surgery 2021; 105(1-3): 649 doi: 10.9738/INTSURG-D-20-00026.1
|
87 |
Nefeli Giannopoulou, Constantina Constantinou. Recent Developments in Diagnostic and Prognostic Biomarkers for Colorectal Cancer: A Narrative Review. Oncology 2023; 101(10): 675 doi: 10.1159/000531474
|
88 |
Takaaki Masuda, Naoki Hayashi, Yosuke Kuroda, Shuhei Ito, Hidetoshi Eguchi, Koshi Mimori. MicroRNAs as Biomarkers in Colorectal Cancer. Cancers 2017; 9(9): 124 doi: 10.3390/cancers9090124
|
89 |
Dazhong Wang, Xin Han, Chan Li, Weijun Bai. FBXL3 is regulated by miRNA-4735-3p and suppresses cell proliferation and migration in non-small cell lung cancer. Pathology - Research and Practice 2019; 215(2): 358 doi: 10.1016/j.prp.2018.12.008
|
90 |
Ga-Bin Park, Jee-Yeong Jeong, Daejin Kim. GLUT5 regulation by AKT1/3-miR-125b-5p downregulation induces migratory activity and drug resistance in TLR-modified colorectal cancer cells. Carcinogenesis 2020; 41(10): 1329 doi: 10.1093/carcin/bgaa074
|
91 |
Antja-Voy Hartley, Matthew Martin, Tao Lu. Advances in the Molecular Understanding of Colorectal Cancer. 2019; doi: 10.5772/intechopen.82572
|
92 |
Andrea Angius, Antonio Mario Scanu, Caterina Arru, Maria Rosaria Muroni, Vincenzo Rallo, Giulia Deiana, Maria Chiara Ninniri, Ciriaco Carru, Alberto Porcu, Giovanna Pira, Paolo Uva, Paolo Cossu-Rocca, Maria Rosaria De Miglio. Portrait of Cancer Stem Cells on Colorectal Cancer: Molecular Biomarkers, Signaling Pathways and miRNAome. International Journal of Molecular Sciences 2021; 22(4): 1603 doi: 10.3390/ijms22041603
|
93 |
Kentaro Inamura, Yuichi Ishikawa. MicroRNA In Lung Cancer: Novel Biomarkers and Potential Tools for Treatment. Journal of Clinical Medicine 2016; 5(3): 36 doi: 10.3390/jcm5030036
|
94 |
Xiaona Lu, Yuyao Li, Yue Li, Xuemei Zhang, Jia Shi, Hai Feng, Zhuo Yu, Yueqiu Gao. Prognostic and predictive biomarkers for anti-EGFR monoclonal antibody therapy in RAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis. BMC Cancer 2023; 23(1) doi: 10.1186/s12885-023-11600-z
|
95 |
Saloni Gill, Peter I. Chater, Matthew D. Wilcox, Jeffrey P. Pearson, Iain A. Brownlee. The impact of dietary fibres on the physiological processes of the large intestine. Bioactive Carbohydrates and Dietary Fibre 2018; 16: 62 doi: 10.1016/j.bcdf.2018.06.001
|